Bio-Rad Laboratories Inc. (BIO)
NYSE: BIO
· Real-Time Price · USD
305.80
11.56 (3.93%)
At close: Oct 03, 2025, 3:59 PM
305.49
-0.10%
After-hours: Oct 03, 2025, 07:36 PM EDT
3.93% (1D)
| Bid | 299 |
| Market Cap | 8.28B |
| Revenue (ttm) | 2.55B |
| Net Income (ttm) | 319.17M |
| EPS (ttm) | 11.08 |
| PE Ratio (ttm) | 27.6 |
| Forward PE | 27.22 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 307.28 |
| Volume | 154,834 |
| Avg. Volume (20D) | 263,798 |
| Open | 296.52 |
| Previous Close | 294.24 |
| Day's Range | 295.57 - 306.02 |
| 52-Week Range | 211.43 - 387.99 |
| Beta | 0.97 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for BIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBio-Rad Laboratories Inc. is scheduled to release its earnings on
Oct 29, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+17.63%
Bio-Rad Laboratories shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
-3.25%
Bio-Rad Laboratories shares are trading higher after the company reported better-than-expected Q2 financial results.
1 month ago · businesswire.com
Bio-Rad's Management to Participate in Upcoming Investor ConferencesHERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that members of the com...
2 months ago · fool.com
Bio-Rad (BIO) Q2 EPS Jumps 51%Bio-Rad (BIO) Q2 EPS Jumps 51%
2 months ago · businesswire.com
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company's mana...
